Rare Disease Advisor

Rare Disease Advisor company information, Employees & Contact Information

Rare Disease Advisor is an online resource for health care professionals who treat patients with rare diseases. Company Overview Haymarket Media offers a wide range of authoritative publications and services for the professional medical community. Rare Disease Advisor is an online resource that provides health care professionals with comprehensive information on important principles of care in rare diseases as well as up-to-date clinical news on the diagnosis and treatment of these conditions. Website features include: • Daily news • Feature articles on key issues in rare disease • Live conference coverage • Expert opinion articles, including exclusive guest editorials from leading rare disease experts • Concise drug monographs • Medical slideshows • Videos • Continuing medical education (CME) activities • And more...
Looking for a particular Rare Disease Advisor employee's phone or email?

Rare Disease Advisor Questions

News

Recognizing the Neuropsychiatric Symptoms of Huntington Disease - Psychiatric Times

Recognizing the Neuropsychiatric Symptoms of Huntington Disease Psychiatric Times

FDA Grants Orphan Drug Designation to Sanofi’s Rare Disease Drug Rilzabrutinib for wAIHA & IgG4-RD - Pharmaceutical Executive

FDA Grants Orphan Drug Designation to Sanofi’s Rare Disease Drug Rilzabrutinib for wAIHA & IgG4-RD Pharmaceutical Executive

Dubai: How 9-year-old with rare disease built virtual reality 'research lab' - Khaleej Times

Dubai: How 9-year-old with rare disease built virtual reality 'research lab' Khaleej Times

The Future of Rare Disease Treatment with Precision Medicine - News-Medical

The Future of Rare Disease Treatment with Precision Medicine News-Medical

FDA Approves Soleno Therapeutics’ Vykat XR for Hyperphagia in Patients with Prader-Willi Syndrome - Pharmaceutical Executive

FDA Approves Soleno Therapeutics’ Vykat XR for Hyperphagia in Patients with Prader-Willi Syndrome Pharmaceutical Executive

A Smoldering Process: A New Way of Thinking about Multiple Sclerosis - Sanofi

A Smoldering Process: A New Way of Thinking about Multiple Sclerosis Sanofi

Tensilon Test: What It Is and Why It's No Longer Used to Diagnose Myasthenia Gravis in the U.S. - Healthline

Tensilon Test: What It Is and Why It's No Longer Used to Diagnose Myasthenia Gravis in the U.S. Healthline

Free Chrome Extension

Find emails, phones & company data instantly

Find verified emails from LinkedIn profiles
Get direct phone numbers & mobile contacts
Access company data & employee information
Works directly on LinkedIn - no copy/paste needed
Get Chrome Extension - Free

Aero Online

Your AI prospecting assistant